This webinar aims to create the dialogue about the impact of crystal meth and opioids on black gay men. Already bearing the burden of HIV, meth and opioid use can be devastating to a community already struggling to find resources. By bringing awareness to this subject, we can begin to shift attention to meet needs of an overlooked community.
Join UCHAPS and NASTAD for a webinar on methamphetamine use and methamphethamine-specific harm reduction practices that can be adopted within health departments, substance use and syringe service programs (SSPs).
Injection drug use presents an enormous HIV prevention challenge throughout the United States. Syringe access programs have proven to be an effective intervention in preventing disease and other health burdens by providing sterile syringes, sterile injection equipment, and education to people who inject drugs, steroids, and hormones.
Transgender populations suffer from a disproportionately high rate of HIV. HIV prevention programs are often a gateway for transgender persons into social service and health care systems so it is critical that these are incorporated into the larger health and wellness initiatives
NCHHSTP AtlasPlus gives you the power to access data reported to CDC’s National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention (NCHHSTP). Use HIV, viral hepatitis, STD, and TB data to create maps, charts, and detailed reports, and analyze trends and patterns.
amfAR's Opioid & Health Indicators database is a window into the opioid epidemic unfolding in every American's backyard—it provides local to national statistics using reliable data sources on new HIV and hepatitis C infections, opioid use and overdose death rates, and the availability of services like drug treatment programs and syringe exchange services.